Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. | Sci Rep | 2022 | 35264596 | PubTator, text mining | PubMed |
| Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer. | Oncol Lett | 2022 | 35261632 | PubTator, text mining | PubMed |
| Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors. | NPJ Precis Oncol | 2022 | 35260767 | PubTator, text mining | PubMed |
| Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification. | Crit Rev Oncol Hematol | 2022 | 35248713 | PubTator, text mining | PubMed |
| Mutation Spectrum of Familial Adenomatous Polyposis Patients in Turkish Population: Identification of 3 Novel APC Mutations. | Turk J Gastroenterol | 2022 | 35238777 | PubTator, text mining | PubMed |
| Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt-Hogg-Dubè Syndrome Family. | Front Oncol | 2022 | 35237525 | PubTator, text mining | PubMed |
| PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components. | Onco Targets Ther | 2022 | 35237050 | PubTator, text mining | PubMed |
| Exercise-mediated reinnervation of skeletal muscle in elderly people: An update. | Eur J Transl Myol | 2022 | 35234025 | PubTator, text mining | PubMed |
| Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer. | EBioMedicine | 2022 | 35231699 | PubTator, text mining | PubMed |
| Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization. | J Clin Oncol | 2022 | 35230882 | PubTator, text mining | PubMed |
| Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients. | Orphanet J Rare Dis | 2022 | 35227301 | PubTator, text mining | PubMed |
| Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength. | Front Oncol | 2022 | 35223509 | PubTator, text mining | PubMed |
| The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. | Nat Cancer | 2022 | 35221333 | PubTator, text mining | PubMed |
| Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa. | BMC Cancer | 2022 | 35216584 | PubTator, text mining | PubMed |
| ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6. | Cancers (Basel) | 2022 | 35205819 | PubTator, text mining | PubMed |
| Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice. | Cancers (Basel) | 2022 | 35205766 | PubTator, text mining | PubMed |
| Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy. | Cancers (Basel) | 2022 | 35205701 | PubTator, text mining | PubMed |
| Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing. | Genes (Basel) | 2022 | 35205332 | PubTator, text mining | PubMed |
| Chronic Generalized Lymphadenopathy in a Child-Progressive Transformation of Germinal Centers (PTGC). | Children (Basel) | 2022 | 35204936 | PubTator, text mining | PubMed |
| PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. | Biomedicines | 2022 | 35203508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=50